Labiotech.eu’s Post

💡 Very insightful article on securing the right mix of funding sources for #biotech startups. 🚀 "The journey to funding a startup in the biotech industry is long and it is not only about the funds but also about the added value investors can bring to your company. The adequate combination of sources vastly depends on your business model but governmental grants and subsidies in addition to VC investments seem to be the way to go in the industry as companies are dealing with long timelines and are rarely able to generate revenue early on."

An insightful article by Labiotech.eu on the challenging journey to funding a biotech venture. It's not just about securing funds but also the value investors can bring. The right mix of dilutive and non-dilutive funding sources is crucial, involving governmental grants, subsidies, VC investments, Corporate VC investments, partnerships, collaborations, and the IPO. The latter is not discussed in this article. Hope to see more on that soon. It's time! 👍👊 #Biotech #Lifesciences #Ecosystembuilding #Startup #ScaleUp #Growth #Funding

How do you fund a #biotech startup? 🏛 Bootstrapping and crowdfunding (not the best options) 🏛 Government grants and subsidies (essential steps) 🏛 Angel investors (overlooked source of funding) 🏛 Venture capital (most important funding sources) 🏛 Corporate venture capital (a strategic investment) 🏛 Strategic partnerships (collaborations) 🏛 Debt financing (clear plan to reach break-even) 🏛 Funding a startup in biotech (a combination of methods) https://lnkd.in/eYzezVmu #biotechnology #funding #biopharma #pharma #investment #investing #startup #startups #leanstartups #vc #venturecapital #angelinvestors #business #businessintelligence #finance #humanresources #NIH #BARDA #ARPAH

Meet the next Venture Partner of ATIF - Avik Arakelian, CFA !🌎 Avik Arakelian is a biotech venture investor with over 10 years of experience managing investments spanning from startup creation stages to IPOs and M&As. Our interview: 1. Why did you join ATIF? We live at a very unique moment in terms of global technological transformations, especially with the integration of AI into our lives, from everyday apps to complex fields like computational biology. Armenia, while being a small country with a challenging history, is facing both difficulties and opportunities in this era. The emergence of new technologies are reducing the impact of geographical and physical boundaries, opening up new possibilities for the country's growth. The key to progress lies in creating an ecosystem that nurtures innovation. I am inspired by the vision of ATIF, a project initiated by my close friends, and joined as a venture advisor to support the fund in making a positive impact. 2. What are the areas of your interest and why? I have been managing venture funds primarily focused on biotech. While my interests extend to space tech and cybersecurity, among others, I am passionate about how new technologies can extend healthy human lifespans. Unfortunately, Armenia ranks below 50th in global healthy life expectancy and even below 60th in total life expectancy. Although this is not the worst case, significant healthcare issues in Armenia could be addressed by novel technologies, from AI-powered early diagnostics of widespread chronic diseases to new targeted therapies. We are actually the first generation to understand why we age at a biological level, and with advances in AI, we finally have the technologies that can address the complexities of human biology. We need platforms to bring these technologies to Armenia. And ATIF should be one of them. 3. What is your vision of the fund at the moment? There are several unique aspects of ATIF that significantly drove my interest in the project. It offers a very unique venture model, which is rare to find elsewhere. First, investors in the ATIF are amazing individuals from all around the world, and they all will be involved in active roles in the fund, unlike in traditional VC funds. Second, the fund is structured under the local regulations of Armenia, providing a direct route to improving the regulatory framework, essential for attracting more investors to our country. This gives us the opportunity to advance in terms of the investment climate and enhance the country’s reputation in the global venture market. I envision seeing more companies from around the world, featuring an Armenian fund as their investor. My vision is for ATIF to become a unique platform for interaction, collaboration, and joint projects, not only for Armenians worldwide but also for global institutions and corporations interested in Armenia as a growing and advancing nation. #ATIF #armtechimpactvc #armtechventures #armenia #startupsarmenia

🚀 New VC fund announcements last week: In last week's venture capital fund announcements, we've witnessed a global presence of funds from various regions. The average fundraise size during this period has been approximately USD 213 million. Key Highlights: ✅ Geographical Reach: 46.15% of the funds operate globally, while others have specific regional focuses. ✅ Seed Stage: 69.23% of the funds focus on supporting startups at the seed stage. ✅ B2B Startups: 69.23% of the funds support B2B (Business to Business) startups. ✅ Pharmaceuticals and Healthcare: 30.77% of the funds have an interest in the pharmaceuticals and healthcare sector. ✅ Artificial Intelligence: 76.92% emphasize investments in AI-related startups. ✅ Sustainable Focus: 61.54% of the funds are committed to sustainability and environmental impact. Oraseya Capital, Korea Investment Partners, Sofinnova Partners, BDC Capital, Andreessen Horowitz, Ankona Capital, Twinco Capital, SYN Ventures, 2100 Ventures, Kamay Ventures, LeverageVC, VisVires Clay Capital fka VisVires New Protein, Garuda Ventures, Bioluminescence Ventures, Generali Ventures Full access to the data for N2 . Eco and/ or Fusion 42 community members. Please DM for deets. *This Investment Thesis data has been 90% produced with our AI Agent using 1st party data. for the ❤️ of startups __________________________________ Connect or Follow DeReK WaTSoN Follow N2   for more updates Join our startup founders community to get actionable insights from industry experts: Fusion-42 ___________________________________ #startups #founders #cofounders #venturecapital #angelinvestors

Founders: understand fund cycles! VCs/Fund Mgrs: more of us doing this 👇🏼👇🏼👇🏼for our ecosystems! One very important thing I didn’t know when raising with The Mother Love was understanding fund cycles, and is one of the most important pieces of info I now pass onto founders. Especially underrepresented founders.

🔔Six facts on new VC funds—— → Geographical Reach: 46% operate globally → Seed Stage: 69% focus on the seed stage → B2B Startups: 69% support B2B startups → Healthcare: 30% explore pharma & health → AI: 76% emphasize AI-related startups → Sustainability: 61% commit to sustainability Do you think this is a result of LP or general market focus? Whatever the case, AI seems here to stay… at least for now. 💡 𝗥𝗮𝗶𝘀𝗶𝗻𝗴 𝗠𝗼𝗻𝗲𝘆 𝗳𝗼𝗿 𝗬𝗼𝘂𝗿 𝗦𝘁𝗮𝗿𝘁𝘂𝗽❓ 🔔 We connect you with investors without any cuts or fees. 𝗔𝗿𝗲 𝘆𝗼𝘂 𝗮𝗻 𝗜𝗻𝘃𝗲𝘀𝘁𝗼𝗿❓ 🔔 Experience the future of early-stage investing with our zero-carry platform. Schedule a demo by sending us a message. #founders #venturecapital #artificialintelligence #investing #venturefund

Seed funding generally represents the first official equity funding stage for startups. This type of early-stage funding is pivotal for most startups, particularly in the biotech field where initial research and development costs can be substantial, because it provides the essential capital needed to transition from concept to early operational stages, such as conducting preliminary research, prototyping, and securing intellectual property. Venture capital firms participate quite frequently in seed rounds these days, providing capital from what is called a fund. A fund is simply a sum of money a group of investors have committed to an investment, and the investors who supply the fund with money are designated as limited partners. Angel investors are typically affluent individuals or experienced entrepreneurs who invest their personal funds in startups. Ultimately, it's not just about securing capital but also about finding the right partners who can provide support, insight, and connections that are essential for navigating the challenging path of biotech innovation.

Some life sciences startups are adopting a "hyper-virtual" business model to minimize costs in order to achieve milestones and attract investor capital. Dive into what sets hyper-virtual companies apart: #lifesciences | #startup | #fundraising

Meet the Geomatrix Investment fund - Empowering Startups Towards Success! We’re proud to spotlight our established Investment fund, dedicated to providing comprehensive support for high-tech companies and startups. Since its inception in 2021, our fund has been instrumental in helping numerous projects navigate the complex landscape of funding and development. We’ve developed a unique investment model exclusive to our Investment fund. This model guarantees investor funds are secure and not exposed to undue risk, while also ensuring project milestones are met with precision. Investments are made incrementally, aligned with the project’s progress, enabling a safer investment strategy that supports steady development. Aviv Antebi, our Founder, shares the vision behind this initiative: "Our Investment fund was created to streamline the investment process for entrepreneurs. By focusing on a single point of contact, we ensure that startups can quickly and efficiently secure the funding they need without the typical runaround." Reut Goldman, our CEO, emphasizes the division's unique approach: "We integrate our extensive knowledge of engineering, technology, and market demands to craft business plans that address the real challenges startups face. This strategic insight ensures that our entrepreneurs are not just dreaming big but also planning realistically." Discover how our Investment fund is changing the game for startups by ensuring they have the resources to bring their innovative ideas to fruition. Learn more about our approach and the startups thriving under our guidance >> https://lnkd.in/d-SjNXJ #Geomatrix #FinanceDivision #Startups #Innovation #Tech #Investment